Changning Wang

30PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Autonomic nervous systemGene and molecular therapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Apr 25, 2026
Synthesis and Evaluation of a PET Radiotracer [18F]LY3000328 Selectively Targeting the Cysteine Protease Cathepsin S.

|Apr 24, 2026
The Development of the Novel Positron Emission Tomography Radiotracer for Selective HDAC8 Imaging.

|Dec 22, 2025
Development of a Novel PET Radioligand for Imaging the Adenosine A2A Receptor in the Brain.

Yanli Wang, Yongle Wang, Yulong Xu

|Dec 05, 2025
Linker-Driven Breakthrough: Design of a Novel Linker for Enhanced Theranostic Performance of FAPI Trimer.

Hua Cheng, Liyan Bai, Xuwei Liu

|Nov 21, 2025
Development and Preclinical Evaluation of Novel F-18-Labeled Dihydropyrazole RIPK1 PET Tracers for Neuroinflammation Imaging.

Hongyan Li, Zeyi Qin, Yanting Zhou

|Nov 20, 2025
Development of a Novel PET Radioligand Targeting PKM2 for Brain Imaging and Alzheimer's Disease Characterization.

Yanli Wang, Yongle Wang, Wei Zhang

Pageof 5

Frequent Collaborators

10 joint publications

Ping Bai

10 joint publications

Can Zhang

9 joint publications

Yulong Xu

6 joint publications

Yanli Wang